Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Isolation and characterization of camelid single-domain antibodies against HER2.

Hussack G, Raphael S, Lowden MJ, Henry KA.

BMC Res Notes. 2018 Dec 5;11(1):866. doi: 10.1186/s13104-018-3955-8.

2.

Oxford nanopore sequencing enables rapid discovery of single-domain antibodies from phage display libraries.

Lowden MJ, Henry KA.

Biotechniques. 2018 Dec;65(6):351-356. doi: 10.2144/btn-2018-0123.

3.

Stability-Diversity Tradeoffs Impose Fundamental Constraints on Selection of Synthetic Human VH/VL Single-Domain Antibodies from In Vitro Display Libraries.

Henry KA, Kim DY, Kandalaft H, Lowden MJ, Yang Q, Schrag JD, Hussack G, MacKenzie CR, Tanha J.

Front Immunol. 2017 Dec 12;8:1759. doi: 10.3389/fimmu.2017.01759. eCollection 2017.

4.

Pyridoxine Toxicity Small Fiber Neuropathy With Dysautonomia: A Case Report.

Bacharach R, Lowden M, Ahmed A.

J Clin Neuromuscul Dis. 2017 Sep;19(1):43-46. doi: 10.1097/CND.0000000000000172.

PMID:
28827489
5.

A disulfide-stabilized human VL single-domain antibody library is a source of soluble and highly thermostable binders.

Henry KA, Kandalaft H, Lowden MJ, Rossotti MA, van Faassen H, Hussack G, Durocher Y, Kim DY, Tanha J.

Mol Immunol. 2017 Oct;90:190-196. doi: 10.1016/j.molimm.2017.07.006. Epub 2017 Aug 15.

PMID:
28820969
6.

Reducing Health Inequities in the U.S.: Recommendations From the NHLBI's Health Inequities Think Tank Meeting.

Sampson UKA, Kaplan RM, Cooper RS, Diez Roux AV, Marks JS, Engelgau MM, Peprah E, Mishoe H, Boulware LE, Felix KL, Califf RM, Flack JM, Cooper LA, Gracia JN, Henderson JA, Davidson KW, Krishnan JA, Lewis TT, Sanchez E, Luban NL, Vaccarino V, Wong WF, Wright JT Jr, Meyers D, Ogedegbe OG, Presley-Cantrell L, Chambers DA, Belis D, Bennett GC, Boyington JE, Creazzo TL, de Jesus JM, Krishnamurti C, Lowden MR, Punturieri A, Shero ST, Young NS, Zou S, Mensah GA.

J Am Coll Cardiol. 2016 Aug 2;68(5):517-524. doi: 10.1016/j.jacc.2016.04.059. Review.

7.

Perspectives from NHLBI Global Health Think Tank Meeting for Late Stage (T4) Translation Research.

Engelgau MM, Peprah E, Sampson UKA, Mishoe H, Benjamin IJ, Douglas PS, Hochman JS, Ridker PM, Brandes N, Checkley W, El-Saharty S, Ezzati M, Hennis A, Jiang L, Krumholz HM, Lamourelle G, Makani J, Narayan KMV, Ohene-Frempong K, Straus SE, Stuckler D, Chambers DA, Belis D, Bennett GC, Boyington JE, Creazzo TL, de Jesus JM, Krishnamurti C, Lowden MR, Punturieri A, Shero ST, Young NS, Zou S, Mensah GA.

Glob Heart. 2017 Dec;12(4):341-348. doi: 10.1016/j.gheart.2016.03.640. Epub 2016 Jul 21. Review.

PMID:
27452772
8.

A Highly Effective Component Vaccine against Nontyphoidal Salmonella enterica Infections.

Ferreira RB, Valdez Y, Coombes BK, Sad S, Gouw JW, Brown EM, Li Y, Grassl GA, Antunes LC, Gill N, Truong M, Scholz R, Reynolds LA, Krishnan L, Zafer AA, Sal-Man N, Lowden MJ, Auweter SD, Foster LJ, Finlay BB.

MBio. 2015 Sep 22;6(5):e01421-15. doi: 10.1128/mBio.01421-15.

9.

Functional and structural diversity in GH62 ╬▒-L-arabinofuranosidases from the thermophilic fungus Scytalidium thermophilum.

Kaur AP, Nocek BP, Xu X, Lowden MJ, Leyva JF, Stogios PJ, Cui H, Di Leo R, Powlowski J, Tsang A, Savchenko A.

Microb Biotechnol. 2015 May;8(3):419-33. doi: 10.1111/1751-7915.12168. Epub 2014 Sep 29.

10.

Looks like a stroke, acts like a stroke, but it's more than a stroke: a case of cerebral mucormycosis.

Ermak D, Kanekar S, Specht CS, Wojnar M, Lowden M.

J Stroke Cerebrovasc Dis. 2014 Sep;23(8):e403-e404. doi: 10.1016/j.jstrokecerebrovasdis.2014.02.024. Epub 2014 Aug 6.

PMID:
25106832
11.

National Bone Health Alliance: an innovative public-private partnership improving America's bone health.

Lee DB, Lowden MR, Patmintra V, Stevenson K.

Curr Osteoporos Rep. 2013 Dec;11(4):348-53. doi: 10.1007/s11914-013-0159-y.

PMID:
24014197
12.

Atorvastatin as novel treatment for neuropathic pain: a case report.

Gillon JT, Smith SE, Lowden MR.

Clin J Pain. 2013 Dec;29(12):e46-8. doi: 10.1097/AJP.0b013e3182a03c2e.

PMID:
23887344
13.

A patient with new onset seizures. Herpes encephalitis.

Ahmed A, Thomas G, Lowden MR.

J Clin Neurosci. 2013 Feb;20(2):300, 334. No abstract available.

PMID:
23431567
14.

Caenorhabditis elegans POT-1 and POT-2 repress telomere maintenance pathways.

Shtessel L, Lowden MR, Cheng C, Simon M, Wang K, Ahmed S.

G3 (Bethesda). 2013 Feb;3(2):305-13. doi: 10.1534/g3.112.004440. Epub 2013 Feb 1.

15.

A patient with confusion and dizziness.

Ahmed A, Specht C, Lowden MR.

J Clin Neurosci. 2012 Sep;19(9):1281; answer 1330. No abstract available.

PMID:
23050267
16.

A patient with short term memory problems and ataxia.

Lowden MR, Ahmed A.

J Clin Neurosci. 2012 Aug;19(8):1148; answer 1198. No abstract available.

PMID:
22930843
17.

Commentary.

Lowden MR.

J Neurosci Rural Pract. 2012 May;3(2):195-6. No abstract available.

18.

A monofocal pontine lesion.

Lowden MR.

J Clin Neurosci. 2012 Mar;19(3):435, 489. No abstract available.

PMID:
22423376
19.

A cervical incidentaloma.

Lowden MR, Ahmed A.

J Clin Neurosci. 2012 Feb;19(2):300, 341. No abstract available.

PMID:
22379621
20.

Quantitative mass spectrometry catalogues Salmonella pathogenicity island-2 effectors and identifies their cognate host binding partners.

Auweter SD, Bhavsar AP, de Hoog CL, Li Y, Chan YA, van der Heijden J, Lowden MJ, Coombes BK, Rogers LD, Stoynov N, Foster LJ, Finlay BB.

J Biol Chem. 2011 Jul 8;286(27):24023-35. doi: 10.1074/jbc.M111.224600. Epub 2011 May 12.

21.

DNA synthesis generates terminal duplications that seal end-to-end chromosome fusions.

Lowden MR, Flibotte S, Moerman DG, Ahmed S.

Science. 2011 Apr 22;332(6028):468-71. doi: 10.1126/science.1199022.

22.

Salmonella phage ST64B encodes a member of the SseK/NleB effector family.

Brown NF, Coombes BK, Bishop JL, Wickham ME, Lowden MJ, Gal-Mor O, Goode DL, Boyle EC, Sanderson KL, Finlay BB.

PLoS One. 2011 Mar 18;6(3):e17824. doi: 10.1371/journal.pone.0017824.

23.

Intracranial focal meningeal enhancement. Wegener's granulomatosis.

Lowden MR, Ahmed A.

J Clin Neurosci. 2010 Apr;17(4):479, 545. No abstract available.

PMID:
20235344
24.

Structure of Vibrio cholerae ToxT reveals a mechanism for fatty acid regulation of virulence genes.

Lowden MJ, Skorupski K, Pellegrini M, Chiorazzo MG, Taylor RK, Kull FJ.

Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):2860-5. doi: 10.1073/pnas.0915021107. Epub 2010 Feb 1.

25.

Chronic non-exertional myalgia and myoadenylate deaminase deficiency: a possible association.

Ahmed A, Lowden MR.

J Clin Med Res. 2009 Apr;1(1):56-7. doi: 10.4021/jocmr2009.04.1231. Epub 2009 Mar 24.

26.

Teaching neuroimages: superficial siderosis.

Lowden MR, Thomas GA.

Neurology. 2009 Feb 24;72(8):e39. doi: 10.1212/01.wnl.0000343053.13886.7e. No abstract available.

PMID:
19237692
27.

Pathogenic adaptation of intracellular bacteria by rewiring a cis-regulatory input function.

Osborne SE, Walthers D, Tomljenovic AM, Mulder DT, Silphaduang U, Duong N, Lowden MJ, Wickham ME, Waller RF, Kenney LJ, Coombes BK.

Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3982-7. doi: 10.1073/pnas.0811669106. Epub 2009 Feb 20.

28.

Prevalence of symptoms suggestive of extra-oesophageal reflux in a general practice population in the UK.

Lowden M, McGlashan JA, Steel A, Strugala V, Dettmar PW.

Logoped Phoniatr Vocol. 2009;34(1):32-5. doi: 10.1080/14015430902735847.

PMID:
19214865
29.

Teaching NeuroImage: idiopathic hypertrophic spinal pachymeningitis.

Lowden MR, Gill D.

Neurology. 2009 Feb 3;72(5):e27. doi: 10.1212/01.wnl.0000341880.99861.1e. No abstract available.

PMID:
19188567
30.

Familial Creutzfeldt-Jakob disease presenting as epilepsia partialis continua.

Lowden MR, Scott K, Kothari MJ.

Epileptic Disord. 2008 Dec;10(4):271-5. doi: 10.1684/epd.2008.0216.

31.

End joining at Caenorhabditis elegans telomeres.

Lowden MR, Meier B, Lee TW, Hall J, Ahmed S.

Genetics. 2008 Oct;180(2):741-54. doi: 10.1534/genetics.108.089920. Epub 2008 Sep 9.

32.

SseL is a salmonella-specific translocated effector integrated into the SsrB-controlled salmonella pathogenicity island 2 type III secretion system.

Coombes BK, Lowden MJ, Bishop JL, Wickham ME, Brown NF, Duong N, Osborne S, Gal-Mor O, Finlay BB.

Infect Immun. 2007 Feb;75(2):574-80. Epub 2006 Dec 11.

33.

Mutator phenotype of Caenorhabditis elegans DNA damage checkpoint mutants.

Harris J, Lowden M, Clejan I, Tzoneva M, Thomas JH, Hodgkin J, Ahmed S.

Genetics. 2006 Oct;174(2):601-16. Epub 2006 Sep 1.

34.

trt-1 is the Caenorhabditis elegans catalytic subunit of telomerase.

Meier B, Clejan I, Liu Y, Lowden M, Gartner A, Hodgkin J, Ahmed S.

PLoS Genet. 2006 Feb;2(2):e18. Epub 2006 Feb 10.

35.

Negative regulation of Salmonella pathogenicity island 2 is required for contextual control of virulence during typhoid.

Coombes BK, Wickham ME, Lowden MJ, Brown NF, Finlay BB.

Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17460-5. Epub 2005 Nov 21.

36.

Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli.

Gauthier A, Robertson ML, Lowden M, Ibarra JA, Puente JL, Finlay BB.

Antimicrob Agents Chemother. 2005 Oct;49(10):4101-9.

Supplemental Content

Loading ...
Support Center